nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP3A4—Temozolomide—malignant glioma	0.337	1	CbGbCtD
Etravirine—Rilpivirine—CYP2B6—malignant glioma	0.0273	1	CrCbGaD
Etravirine—Opportunistic infection—Temozolomide—malignant glioma	0.0185	0.0492	CcSEcCtD
Etravirine—Cerebral haemorrhage—Carmustine—malignant glioma	0.0139	0.0371	CcSEcCtD
Etravirine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0135	0.0358	CcSEcCtD
Etravirine—Disturbance in attention—Temozolomide—malignant glioma	0.0086	0.0229	CcSEcCtD
Etravirine—Gynaecomastia—Carmustine—malignant glioma	0.0069	0.0184	CcSEcCtD
Etravirine—Diabetes mellitus—Carmustine—malignant glioma	0.00643	0.0171	CcSEcCtD
Etravirine—Hepatic failure—Temozolomide—malignant glioma	0.00602	0.016	CcSEcCtD
Etravirine—Amnesia—Carmustine—malignant glioma	0.00595	0.0159	CcSEcCtD
Etravirine—Amnesia—Temozolomide—malignant glioma	0.00575	0.0153	CcSEcCtD
Etravirine—Dry skin—Temozolomide—malignant glioma	0.00496	0.0132	CcSEcCtD
Etravirine—Breast disorder—Temozolomide—malignant glioma	0.00489	0.013	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00487	0.013	CcSEcCtD
Etravirine—Abdominal distension—Temozolomide—malignant glioma	0.0047	0.0125	CcSEcCtD
Etravirine—Hyperglycaemia—Carmustine—malignant glioma	0.00436	0.0116	CcSEcCtD
Etravirine—Renal failure—Carmustine—malignant glioma	0.00424	0.0113	CcSEcCtD
Etravirine—Neuropathy peripheral—Carmustine—malignant glioma	0.00423	0.0112	CcSEcCtD
Etravirine—Hyperglycaemia—Temozolomide—malignant glioma	0.00421	0.0112	CcSEcCtD
Etravirine—Stomatitis—Carmustine—malignant glioma	0.0042	0.0112	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00413	0.011	CcSEcCtD
Etravirine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00408	0.0109	CcSEcCtD
Etravirine—Stomatitis—Temozolomide—malignant glioma	0.00406	0.0108	CcSEcCtD
Etravirine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00394	0.0105	CcSEcCtD
Etravirine—Hypoaesthesia—Carmustine—malignant glioma	0.00385	0.0103	CcSEcCtD
Etravirine—Connective tissue disorder—Carmustine—malignant glioma	0.0038	0.0101	CcSEcCtD
Etravirine—Hepatitis—Temozolomide—malignant glioma	0.00374	0.00996	CcSEcCtD
Etravirine—Hypoaesthesia—Temozolomide—malignant glioma	0.00372	0.00991	CcSEcCtD
Etravirine—Urinary tract disorder—Temozolomide—malignant glioma	0.00369	0.00983	CcSEcCtD
Etravirine—Connective tissue disorder—Temozolomide—malignant glioma	0.00368	0.00978	CcSEcCtD
Etravirine—Urethral disorder—Temozolomide—malignant glioma	0.00367	0.00976	CcSEcCtD
Etravirine—Eye disorder—Carmustine—malignant glioma	0.00362	0.00963	CcSEcCtD
Etravirine—Erythema multiforme—Temozolomide—malignant glioma	0.00354	0.00941	CcSEcCtD
Etravirine—Eye disorder—Temozolomide—malignant glioma	0.0035	0.0093	CcSEcCtD
Etravirine—Cardiac disorder—Temozolomide—malignant glioma	0.00347	0.00924	CcSEcCtD
Etravirine—Angiopathy—Temozolomide—malignant glioma	0.00339	0.00903	CcSEcCtD
Etravirine—Mental disorder—Carmustine—malignant glioma	0.00339	0.00903	CcSEcCtD
Etravirine—Immune system disorder—Temozolomide—malignant glioma	0.00338	0.00899	CcSEcCtD
Etravirine—Mediastinal disorder—Temozolomide—malignant glioma	0.00337	0.00897	CcSEcCtD
Etravirine—Malnutrition—Carmustine—malignant glioma	0.00337	0.00897	CcSEcCtD
Etravirine—Mental disorder—Temozolomide—malignant glioma	0.00328	0.00872	CcSEcCtD
Etravirine—Malnutrition—Temozolomide—malignant glioma	0.00326	0.00867	CcSEcCtD
Etravirine—Vision blurred—Carmustine—malignant glioma	0.00317	0.00845	CcSEcCtD
Etravirine—Tremor—Carmustine—malignant glioma	0.00316	0.0084	CcSEcCtD
Etravirine—Anaemia—Carmustine—malignant glioma	0.00311	0.00829	CcSEcCtD
Etravirine—Vision blurred—Temozolomide—malignant glioma	0.00307	0.00817	CcSEcCtD
Etravirine—Tremor—Temozolomide—malignant glioma	0.00305	0.00812	CcSEcCtD
Etravirine—Ill-defined disorder—Temozolomide—malignant glioma	0.00302	0.00804	CcSEcCtD
Etravirine—Anaemia—Temozolomide—malignant glioma	0.00301	0.00801	CcSEcCtD
Etravirine—Angioedema—Temozolomide—malignant glioma	0.00297	0.00792	CcSEcCtD
Etravirine—Malaise—Temozolomide—malignant glioma	0.00294	0.00782	CcSEcCtD
Etravirine—Vertigo—Temozolomide—malignant glioma	0.00292	0.00779	CcSEcCtD
Etravirine—Convulsion—Carmustine—malignant glioma	0.00292	0.00777	CcSEcCtD
Etravirine—Hypertension—Carmustine—malignant glioma	0.00291	0.00774	CcSEcCtD
Etravirine—Anxiety—Carmustine—malignant glioma	0.00286	0.00761	CcSEcCtD
Etravirine—Convulsion—Temozolomide—malignant glioma	0.00282	0.00751	CcSEcCtD
Etravirine—Hypertension—Temozolomide—malignant glioma	0.00281	0.00748	CcSEcCtD
Etravirine—Confusional state—Carmustine—malignant glioma	0.00277	0.00738	CcSEcCtD
Etravirine—Anxiety—Temozolomide—malignant glioma	0.00276	0.00735	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00275	0.00733	CcSEcCtD
Etravirine—Discomfort—Temozolomide—malignant glioma	0.00274	0.00729	CcSEcCtD
Etravirine—Infection—Carmustine—malignant glioma	0.00273	0.00727	CcSEcCtD
Etravirine—Dry mouth—Temozolomide—malignant glioma	0.00271	0.00722	CcSEcCtD
Etravirine—Thrombocytopenia—Carmustine—malignant glioma	0.00269	0.00717	CcSEcCtD
Etravirine—Confusional state—Temozolomide—malignant glioma	0.00268	0.00713	CcSEcCtD
Etravirine—Infection—Temozolomide—malignant glioma	0.00264	0.00703	CcSEcCtD
Etravirine—Anorexia—Carmustine—malignant glioma	0.00262	0.00698	CcSEcCtD
Etravirine—Nervous system disorder—Temozolomide—malignant glioma	0.00261	0.00694	CcSEcCtD
Etravirine—Thrombocytopenia—Temozolomide—malignant glioma	0.0026	0.00693	CcSEcCtD
Etravirine—Skin disorder—Temozolomide—malignant glioma	0.00258	0.00687	CcSEcCtD
Etravirine—Hyperhidrosis—Temozolomide—malignant glioma	0.00257	0.00684	CcSEcCtD
Etravirine—Anorexia—Temozolomide—malignant glioma	0.00253	0.00674	CcSEcCtD
Etravirine—Insomnia—Carmustine—malignant glioma	0.00249	0.00662	CcSEcCtD
Etravirine—Paraesthesia—Carmustine—malignant glioma	0.00247	0.00657	CcSEcCtD
Etravirine—Somnolence—Carmustine—malignant glioma	0.00244	0.00651	CcSEcCtD
Etravirine—Insomnia—Temozolomide—malignant glioma	0.0024	0.0064	CcSEcCtD
Etravirine—Decreased appetite—Carmustine—malignant glioma	0.00239	0.00636	CcSEcCtD
Etravirine—Paraesthesia—Temozolomide—malignant glioma	0.00239	0.00635	CcSEcCtD
Etravirine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00237	0.00632	CcSEcCtD
Etravirine—Somnolence—Temozolomide—malignant glioma	0.00236	0.00629	CcSEcCtD
Etravirine—Pain—Carmustine—malignant glioma	0.00235	0.00626	CcSEcCtD
Etravirine—Constipation—Carmustine—malignant glioma	0.00235	0.00626	CcSEcCtD
Etravirine—Decreased appetite—Temozolomide—malignant glioma	0.00231	0.00615	CcSEcCtD
Etravirine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00229	0.00611	CcSEcCtD
Etravirine—Fatigue—Temozolomide—malignant glioma	0.00229	0.0061	CcSEcCtD
Etravirine—Pain—Temozolomide—malignant glioma	0.00227	0.00605	CcSEcCtD
Etravirine—Constipation—Temozolomide—malignant glioma	0.00227	0.00605	CcSEcCtD
Etravirine—Feeling abnormal—Carmustine—malignant glioma	0.00227	0.00603	CcSEcCtD
Etravirine—Gastrointestinal pain—Carmustine—malignant glioma	0.00225	0.00599	CcSEcCtD
Etravirine—Feeling abnormal—Temozolomide—malignant glioma	0.00219	0.00583	CcSEcCtD
Etravirine—Body temperature increased—Carmustine—malignant glioma	0.00217	0.00579	CcSEcCtD
Etravirine—Abdominal pain—Carmustine—malignant glioma	0.00217	0.00579	CcSEcCtD
Etravirine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00217	0.00578	CcSEcCtD
Etravirine—Abdominal pain—Temozolomide—malignant glioma	0.0021	0.00559	CcSEcCtD
Etravirine—Body temperature increased—Temozolomide—malignant glioma	0.0021	0.00559	CcSEcCtD
Etravirine—Hypersensitivity—Carmustine—malignant glioma	0.00203	0.00539	CcSEcCtD
Etravirine—Asthenia—Carmustine—malignant glioma	0.00197	0.00525	CcSEcCtD
Etravirine—Hypersensitivity—Temozolomide—malignant glioma	0.00196	0.00521	CcSEcCtD
Etravirine—Asthenia—Temozolomide—malignant glioma	0.00191	0.00507	CcSEcCtD
Etravirine—Diarrhoea—Carmustine—malignant glioma	0.00188	0.00501	CcSEcCtD
Etravirine—Dizziness—Carmustine—malignant glioma	0.00182	0.00484	CcSEcCtD
Etravirine—Diarrhoea—Temozolomide—malignant glioma	0.00182	0.00484	CcSEcCtD
Etravirine—Dizziness—Temozolomide—malignant glioma	0.00176	0.00468	CcSEcCtD
Etravirine—Vomiting—Carmustine—malignant glioma	0.00175	0.00465	CcSEcCtD
Etravirine—Rash—Carmustine—malignant glioma	0.00173	0.00461	CcSEcCtD
Etravirine—Dermatitis—Carmustine—malignant glioma	0.00173	0.00461	CcSEcCtD
Etravirine—Headache—Carmustine—malignant glioma	0.00172	0.00459	CcSEcCtD
Etravirine—Vomiting—Temozolomide—malignant glioma	0.00169	0.0045	CcSEcCtD
Etravirine—Rash—Temozolomide—malignant glioma	0.00168	0.00446	CcSEcCtD
Etravirine—Dermatitis—Temozolomide—malignant glioma	0.00167	0.00446	CcSEcCtD
Etravirine—Headache—Temozolomide—malignant glioma	0.00166	0.00443	CcSEcCtD
Etravirine—Nausea—Carmustine—malignant glioma	0.00163	0.00435	CcSEcCtD
Etravirine—Nausea—Temozolomide—malignant glioma	0.00158	0.0042	CcSEcCtD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000975	0.00374	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000925	0.00355	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000921	0.00353	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2B6—malignant glioma	0.000918	0.00352	CbGpPWpGaD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000875	0.00336	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000857	0.00329	CbGpPWpGaD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000846	0.00325	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—IDH1—malignant glioma	0.00084	0.00322	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—SPHK1—malignant glioma	0.000813	0.00312	CbGpPWpGaD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000809	0.0031	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000807	0.0031	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000801	0.00307	CbGpPWpGaD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000798	0.00306	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CYP2C18—malignant glioma	0.000796	0.00305	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.000786	0.00302	CbGpPWpGaD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000756	0.0029	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000751	0.00288	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000713	0.00274	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2B6—malignant glioma	0.000708	0.00272	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2B6—malignant glioma	0.000698	0.00268	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000695	0.00267	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000684	0.00262	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00066	0.00253	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.000645	0.00248	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTT1—malignant glioma	0.000644	0.00247	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000636	0.00244	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	0.000614	0.00235	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	0.000605	0.00232	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS1—malignant glioma	0.000603	0.00232	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000601	0.00231	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000585	0.00225	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000578	0.00222	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—BCHE—malignant glioma	0.000561	0.00215	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.00056	0.00215	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00056	0.00215	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—SLC5A5—malignant glioma	0.000554	0.00213	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000552	0.00212	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000551	0.00211	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000547	0.0021	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00054	0.00207	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000526	0.00202	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000524	0.00201	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000519	0.00199	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000512	0.00197	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000507	0.00194	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000498	0.00191	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000496	0.0019	CbGpPWpGaD
Etravirine—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000479	0.00184	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000465	0.00178	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000456	0.00175	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000453	0.00174	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000453	0.00174	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTP1—malignant glioma	0.000446	0.00171	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000437	0.00168	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CAT—malignant glioma	0.000434	0.00167	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CD80—malignant glioma	0.000428	0.00164	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000426	0.00163	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000424	0.00163	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.00042	0.00161	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	0.000417	0.0016	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000416	0.0016	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NCOR1—malignant glioma	0.00041	0.00157	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000381	0.00146	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000369	0.00142	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000364	0.0014	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000348	0.00133	CbGpPWpGaD
Etravirine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000344	0.00132	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000344	0.00132	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RTEL1—malignant glioma	0.000339	0.0013	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000339	0.0013	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000338	0.0013	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CAV1—malignant glioma	0.000334	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000333	0.00128	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000325	0.00125	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000324	0.00124	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000319	0.00123	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000319	0.00123	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000317	0.00122	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000314	0.00121	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000314	0.0012	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000309	0.00119	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CG—malignant glioma	0.000304	0.00117	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000302	0.00116	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000302	0.00116	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000301	0.00115	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL2—malignant glioma	0.0003	0.00115	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000299	0.00115	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000298	0.00115	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000295	0.00113	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PPARG—malignant glioma	0.000294	0.00113	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.00028	0.00107	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.000272	0.00104	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CD—malignant glioma	0.000268	0.00103	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.000255	0.00098	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000249	0.000954	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000243	0.000932	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000241	0.000923	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CB—malignant glioma	0.000233	0.000895	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTGS2—malignant glioma	0.000231	0.000887	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000227	0.00087	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000219	0.000842	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000219	0.00084	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000218	0.000835	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000211	0.000809	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000209	0.000803	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.000208	0.000799	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000207	0.000794	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000204	0.000783	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PTEN—malignant glioma	0.000202	0.000774	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—COX8A—malignant glioma	0.0002	0.000767	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—COX8A—malignant glioma	0.000195	0.000748	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000188	0.000722	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—COX8A—malignant glioma	0.000182	0.000699	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000179	0.000685	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000177	0.000681	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ASMT—malignant glioma	0.00017	0.000652	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000168	0.000646	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000166	0.000637	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000166	0.000637	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ASMT—malignant glioma	0.000166	0.000636	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000166	0.000636	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000165	0.000635	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000164	0.000628	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000163	0.000625	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.00016	0.000614	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCAN—malignant glioma	0.00016	0.000613	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCAN—malignant glioma	0.000156	0.000598	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000155	0.000594	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000152	0.000584	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000151	0.000581	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.000148	0.00057	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCAN—malignant glioma	0.000146	0.000559	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000145	0.000556	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—malignant glioma	0.000142	0.000546	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.000139	0.000535	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH2—malignant glioma	0.000129	0.000494	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000126	0.000484	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH2—malignant glioma	0.000126	0.000482	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000121	0.000466	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2B6—malignant glioma	0.000121	0.000464	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COX8A—malignant glioma	0.00012	0.000461	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2B6—malignant glioma	0.000118	0.000453	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH2—malignant glioma	0.000117	0.00045	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—malignant glioma	0.000116	0.000446	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000116	0.000445	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000113	0.000435	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH1—malignant glioma	0.000111	0.000425	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000111	0.000425	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.00011	0.000424	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH1—malignant glioma	0.000108	0.000415	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000108	0.000414	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000107	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SPHK1—malignant glioma	0.000107	0.000411	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2C18—malignant glioma	0.000105	0.000403	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SPHK1—malignant glioma	0.000105	0.000401	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2C18—malignant glioma	0.000102	0.000393	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ASMT—malignant glioma	0.000102	0.000392	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH1—malignant glioma	0.000101	0.000387	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.9e-05	0.00038	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	9.84e-05	0.000378	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SPHK1—malignant glioma	9.77e-05	0.000375	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCAN—malignant glioma	9.6e-05	0.000369	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2C18—malignant glioma	9.57e-05	0.000367	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	9.52e-05	0.000365	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.02e-05	0.000346	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.01e-05	0.000346	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.7e-05	0.000334	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—malignant glioma	8.49e-05	0.000326	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—malignant glioma	8.28e-05	0.000318	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.22e-05	0.000315	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	8.04e-05	0.000309	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS1—malignant glioma	7.95e-05	0.000305	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.93e-05	0.000304	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.92e-05	0.000304	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS1—malignant glioma	7.76e-05	0.000298	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH2—malignant glioma	7.74e-05	0.000297	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—malignant glioma	7.74e-05	0.000297	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—BCHE—malignant glioma	7.39e-05	0.000284	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A5—malignant glioma	7.3e-05	0.00028	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.28e-05	0.000279	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS1—malignant glioma	7.25e-05	0.000278	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.23e-05	0.000277	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—BCHE—malignant glioma	7.22e-05	0.000277	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A5—malignant glioma	7.13e-05	0.000274	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.91e-05	0.000265	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.84e-05	0.000263	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—BCHE—malignant glioma	6.74e-05	0.000259	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.66e-05	0.000256	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH1—malignant glioma	6.66e-05	0.000255	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.57e-05	0.000252	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SPHK1—malignant glioma	6.44e-05	0.000247	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.31e-05	0.000242	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.3e-05	0.000242	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.24e-05	0.000239	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.97e-05	0.000229	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—malignant glioma	5.88e-05	0.000226	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—malignant glioma	5.74e-05	0.00022	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAT—malignant glioma	5.72e-05	0.00022	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAT—malignant glioma	5.59e-05	0.000214	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.44e-05	0.000209	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOR1—malignant glioma	5.41e-05	0.000207	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—malignant glioma	5.36e-05	0.000206	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOR1—malignant glioma	5.28e-05	0.000202	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAT—malignant glioma	5.22e-05	0.0002	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—malignant glioma	5.1e-05	0.000196	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOR1—malignant glioma	4.93e-05	0.000189	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS1—malignant glioma	4.78e-05	0.000184	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—BCHE—malignant glioma	4.45e-05	0.000171	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAV1—malignant glioma	4.41e-05	0.000169	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.39e-05	0.000169	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAV1—malignant glioma	4.3e-05	0.000165	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.21e-05	0.000162	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAV1—malignant glioma	4.02e-05	0.000154	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.01e-05	0.000154	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—malignant glioma	3.92e-05	0.00015	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARG—malignant glioma	3.87e-05	0.000149	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.84e-05	0.000147	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARG—malignant glioma	3.78e-05	0.000145	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.66e-05	0.00014	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.54e-05	0.000136	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARG—malignant glioma	3.53e-05	0.000136	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.53e-05	0.000135	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—malignant glioma	3.44e-05	0.000132	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAT—malignant glioma	3.44e-05	0.000132	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.25e-05	0.000125	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.22e-05	0.000123	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.08e-05	0.000118	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.05e-05	0.000117	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—malignant glioma	3e-05	0.000115	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—malignant glioma	2.97e-05	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.8e-05	0.000108	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.78e-05	0.000107	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—malignant glioma	2.66e-05	0.000102	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAV1—malignant glioma	2.65e-05	0.000102	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—malignant glioma	2.59e-05	9.96e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—malignant glioma	2.42e-05	9.3e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.41e-05	9.26e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARG—malignant glioma	2.33e-05	8.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.12e-05	8.14e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.88e-05	7.2e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.85e-05	7.1e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.83e-05	7.03e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.83e-05	7.02e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.71e-05	6.56e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—malignant glioma	1.6e-05	6.13e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—malignant glioma	1.53e-05	5.88e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—malignant glioma	1.5e-05	5.74e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—malignant glioma	1.4e-05	5.36e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.13e-05	4.33e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—malignant glioma	9.21e-06	3.53e-05	CbGpPWpGaD
